Literature DB >> 27659878

Worldwide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT).

Khaldoun G Tarakji1, Suneet Mittal2, Charles Kennergren3, Ralph Corey4, Jeanne Poole5, Kurt Stromberg6, Daniel R Lexcen6, Bruce L Wilkoff7.   

Abstract

BACKGROUND: Cardiac implantable electronic device (CIED) infection is a major complication that is associated with significant morbidity and mortality. The aim of this study is to determine whether Medtronic TYRX absorbable envelope reduces the risk of CIED infection through 12 months of follow-up post procedure.
METHODS: WRAP-IT is a randomized, prospective, multi center, international, single-blinded study. Up to 7,764 subjects who are undergoing CIED generator replacement, upgrade, or revision, or a de novo CRT-D implant, will be enrolled and randomized (1:1) to receive the TYRX envelope or not. The primary endpoint is major CIED infection throughout 12 months of follow up after the procedure. Data will be analyzed with an intention to treat approach. WRAP-IT will also assess the performance of Medtronic's lead monitoring algorithms in subjects whose CIED includes a transvenous right ventricular defibrillation system.
CONCLUSIONS: WRAP-IT is a large randomized clinical trial that will assess the efficacy of TYRX absorbable envelope in reducing CIED infection, define its cost effectiveness, and will also provide a unique opportunity to better understand the pathophysiology and risk factors for CIED infection.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27659878     DOI: 10.1016/j.ahj.2016.06.010

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

Review 1.  Transvenous Lead Extractions: Current Approaches and Future Trends.

Authors:  Adryan A Perez; Frank W Woo; Darren C Tsang; Roger G Carrillo
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

2.  Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study.

Authors:  Igor Diemberger; Rachele Bonfiglioli; Cristian Martignani; Maddalena Graziosi; Mauro Biffi; Stefano Lorenzetti; Matteo Ziacchi; Cristina Nanni; Stefano Fanti; Giuseppe Boriani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-09-08       Impact factor: 9.236

3.  Periprocedural Antibiotic Prophylaxis for Cardiac Implantable Electrical Device Procedures: Results From a Heart Rhythm Society Survey.

Authors:  Anuj Basil; Steven A Lubitz; Peter A Noseworthy; Matthew R Reynolds; Howard Gold; David Yassa; Daniel Kramer
Journal:  JACC Clin Electrophysiol       Date:  2017-06

4.  Epidemiology of cardiac implantable electronic device infections: incidence and risk factors.

Authors:  Hui-Chen Han; Nathaniel M Hawkins; Charles M Pearman; David H Birnie; Andrew D Krahn
Journal:  Europace       Date:  2021-06-23       Impact factor: 5.214

5.  Cardiac implantable electronic device infections: Observational data from a tertiary care center in Lebanon.

Authors:  Marwan Refaat; Patrick Zakka; Maurice Khoury; Hassan Chami; Shareef Mansour; Bernard Harbieh; Bernard Abi-Saleh; Abdul Rahman Bizri
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

6.  Vancomycin Wrap for Anterior Cruciate Ligament Surgery: Molecular Insights.

Authors:  Caroline M Atherton; Simon J Spencer; Katy McCall; Emma Garcia-Melchor; William J Leach; Michael Mullen; Brian P Rooney; Colin Walker; Iain B McInnes; Neal L Millar; Moeed Akbar
Journal:  Am J Sports Med       Date:  2021-01-06       Impact factor: 6.202

7.  The Risk of Cardiac Device-Related Infection in Bacteremic Patients Is Species Specific: Results of a 12-Year Prospective Cohort.

Authors:  Stacey A Maskarinec; Joshua T Thaden; Derek D Cyr; Felicia Ruffin; Maria Souli; Vance G Fowler
Journal:  Open Forum Infect Dis       Date:  2017-06-21       Impact factor: 3.835

Review 8.  Complications of electrotherapy - the dark side of treatment with cardiac implantable electronic devices.

Authors:  Szymon Domagała; Michał Domagała; Jakub Chyła; Celina Wojciechowska; Marianna Janion; Anna Polewczyk
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-03-22       Impact factor: 1.426

9.  Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial.

Authors:  Bruce L Wilkoff; Giuseppe Boriani; Suneet Mittal; Jeanne E Poole; Charles Kennergren; G Ralph Corey; John C Love; Ralph Augostini; Svein Faerestrand; Sherman S Wiggins; Jeff S Healey; Reece Holbrook; Jeffrey D Lande; Daniel R Lexcen; Sarah Willey; Khaldoun G Tarakji
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-04-12

10.  Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.

Authors:  Bruce L Wilkoff; Giuseppe Boriani; Suneet Mittal; Jeanne E Poole; Charles Kennergren; G Ralph Corey; Andrew D Krahn; Edward J Schloss; Jose L Gallastegui; Robert A Pickett; Rudolph F Evonich; Steven F Roark; Denise M Sorrentino; Darius P Sholevar; Edmond M Cronin; Brett J Berman; David W Riggio; Hafiza H Khan; Marc T Silver; Jack Collier; Zayd Eldadah; Reece Holbrook; Jeff D Lande; Daniel R Lexcen; Swathi Seshadri; Khaldoun G Tarakji
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.